NEW YORK -- Japanese drugmaker Takeda Pharmaceutical is aiming to roll out an antibody treatment for COVID-19 as early as this year, as it joins global big pharma's pledge to rise to the occasion amid a global pandemic.
Pharmaceuticals
Japan's Takeda in push to debut COVID-19 treatment this year
Drugmaker joins big pharma's commitment to pool resources in fight against virus
Takeda hopes to launch an antibody treatment for COVID-19 this year. © Reuters
Read Next
Latest on Pharmaceuticals
